Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA's New Game Plan For Digital Health

Executive Summary

Commissioner Scott Gottlieb outlined his plans to implement software provisions of the 21st Century Cures Act and go much further than that in clarifying regulatory policy and piloting novel strategies to streamline the path to market for digital health technologies.

Advertisement

Related Content

Hiring Plans Are Central To US FDA's Digital Health Plan
Orphan Drug Development May Be Well-Suited To Digital/Wearables
Software At The Speed Of Trust: US FDA Launches Pilot To Expedite Digital Health Products
US FDA: 510(k)-Exempt Class II Devices Should Withdraw Applications
21st Century Cures Implementation: Device Provision Updates
US FDA Collecting Feedback On Digital Health Plan
Consumer-'Empowering' Devices Called Out In Gottlieb's First FDA Speech
User-Fee Facts: 10 Key Medtech Details From US FDA Agreements
Software Fast Track? US FDA Asks Developers To Envision 'Precheck' Program
'Cures' Bill Circumvents FDA On Medical Software Regs

Topics

Advertisement
UsernamePublicRestriction

Register

MT105025

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel